Abbott Laboratories (ABT) Income Statement

Income Statement for Abbott Laboratories  (ABT) 
$ 55.11   -0.15 (-0.27%) Volume: 5.51 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 55.0614   -0.0486 (-0.09%) Volume: 159.12 k 5:19 PM EST Feb 10, 2012
Statement: View:
Income [+] in Millions of Dollars
12/2011 12/2010 12/2009 12/2008 12/2007
Operating Revenue 38,851 35,167 30,765 29,528 25,914
Total Revenue 38,851 35,167 30,765 29,528 25,914
Adjustments to Revenue N/A - - - -
Cost of Revenue (15,541) (12,041) (11,120) (10,773) (9,567)
Cost of Sales With Depreciation 15,541 14,665 13,209 12,612 11,422
Gross Margin 23,310 23,126 19,645 18,754 16,347
Gross Operating Profit 23,310 23,126 19,645 18,754 16,347
Selling/General/Admin Expense (12,756) (10,376) (8,406) (8,436) (7,408)
Research & Development (4,802) (4,038) (2,914) (2,689) (2,506)
Advertising N/A - - - -
EBITDA (Operating Income Before Depreciation) 5,752 8,712 8,325 7,630 6,433
Depreciation & Amortization N/A (2,624) (2,090) (1,839) (1,855)
Depreciation, Unreconciled N/A - - - -
Amortization N/A - - - -
Amortization of Intangibles N/A - - - -
Operating Income 5,752 6,088 6,236 5,791 4,579
Operating Profit After Depreciation 5,752 6,088 6,236 5,791 4,579
Interest Income N/A 105 138 201 137
Earnings from Equity Interest N/A - - - 498
Other Income, Net (108) 73 1,340 490 (151)
Income, Acquired in Process R&D N/A - - (97) -
Income, Restructuring and M&A N/A - - - -
Other Special Charges N/A - - - -
Total Income Before Interest Expense (EBIT) 5,644 6,266 7,713 6,385 5,063
Interest Expense (445) (553) (520) (528) (593)
Income Before Tax 5,199 5,713 7,194 5,856 4,470
Income Taxes (470) (1,087) (1,448) (1,122) (863)
Minority Interest N/A - - - -
Preferred Securities of Subsidiary Trust N/A - - - -
Other Special Charges 5,199 5,713 7,194 5,856 4,470
Net Income from Continuing Operations 4,729 4,626 5,746 4,734 3,606
Net Income from Discontinued Operations - - - 147 -
Net Income from Total Operations 4,729 4,626 5,746 4,881 3,606
Normalized Income N/A 4,626 5,746 4,831 3,606
Extraordinary Income/Loss - - - - -
Special Income/Charges N/A - - (97) -
Income from Cum. Effect of Acct Change - - - - -
Income from Tax Loss Carryforward - - - - -
Net Income Available for Common N/A 4,626 5,746 4,734 3,606
Other Gains - - - - -
Total Net Income 4,729 4,626 5,746 4,881 3,606
Net Income Available for Common N/A 4,626 5,746 4,734 3,606
Results [+] in Dollars (Preferred Dividends in Millions)
12/2011 12/2010 12/2009 12/2008 12/2007
Dividends Paid Per Share 1.88 1.72 1.56 1.41 1.27
Preferred Dividends N/A - - - -
Basic EPS from Continuing Operations 3.01 2.98 3.71 3.06 2.34
Basic EPS from Discontinued Operations 0.00 0.00 0.00 0.10 0.00
Basic EPS from Extraordinary Income Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Basic EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Total Net Income 3.01 2.98 3.71 3.16 2.34
Basic Normalized Net Income per Share N/A 2.98 3.71 3.12 2.34
Basic EPS from Total Operations 3.01 2.98 3.71 3.16 2.34
Diluted EPS from Continuing Operations 3.01 2.96 3.69 3.03 2.31
Diluted EPS from Discontinued Operations 0.00 0.00 0.00 0.09 0.00
Diluted EPS from Extraordinary Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Total Net Income 3.01 2.96 3.69 3.12 2.31
Diluted Normalized Net Income per Share N/A 2.96 3.69 3.09 2.31
Excise Tax N/A - - - -
Diluted EPS from Total Operations 3.01 2.96 3.69 3.12 2.31